News
Company News & Updates
Legal
Awards
Product Development
Performance
Regulatory
Industry
Clinical Results
Patents
Clinical Results
SHEA 2026: Stillwater Medical Center presented study comparing the impact of two diversion devices.
The hospital compared contamination reduction using Kurin’s automatic device (59.3%) and Steripath’s manual device (39.4%). Ultimately, the facility achieved an overall rate of 1.09% and continue to see similar results with Kurin.
April 18, 2026
Legal
Kurin Prevails in Federal Appellate Court in Long-Running Litigation with Magnolia Medical Technologies
March 11, 2026
Clinical Results
Kurin and Crouse Hospital: A Transformative Partnership in Reducing Contaminated Blood Cultures
June 3, 2025
Performance
Kurin Works with The Ohio State University Wexner Medical Center on Patient Safety and Increased Access to High Quality Healthcare
August 6, 2024
Patents
USPTO Examiner Affirms Rejection of Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
March 6, 2024
Patents
USPTO Issues Final Rejection of Magnolia Medical’s ‘483 Patent at Issue in Litigation
December 6, 2023
Patents
USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
August 15, 2023
Patents
Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
August 10, 2023
Product Development
Kurin Launches Kurin Jet, Redefining the Blood Culture Contamination Device Market
July 12, 2023
Patents
USPTO Agrees to Kurin’s Request to Review Validity of Magnolia Medical’s ‘483 Patent
May 3, 2023
Regulatory
Kurin Receives 510k from the FDA with Indication to Reduce Blood Culture Contaminations
May 2, 2023
Industry
Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination
March 14, 2023
Product Development
Kurin Announces Kurin Jet, A Quantum Leap Forward in Devices Designed to Address Blood Culture Contamination
February 15, 2023
Product Development
Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle
September 7, 2022
Patents
U.S. District Court Enters Judgment of No Infringement of Patent Asserted Against Kurin Inc. by Magnolia Medical Technologies, Inc.
June 16, 2022
Product Development
Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System
February 23, 2022
Industry
Kurin, Inc. Announces Agreement with AllSpire Health GPO to Impact Contaminated Blood Cultures
January 18, 2022
Clinical Results
Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™
October 5, 2021
Clinical Results
Kurin, Inc. announces results on Kurin® efficacy from Oishei Children’s Hospital with zero blood culture contaminations
July 21, 2021
Patents
Kurin, Inc. Announces Removal of Magnolia Patent Infringement Lawsuit Trial Date
March 23, 2021
Clinical Results
Kurin, Inc. announces peer-reviewed publication on Kurin® efficacy from Central Texas Veterans Health Care System
January 19, 2021
Awards
Kurin, Inc. honored by MD Tech Review in annual listing of top Infection Control solutions
December 24, 2020
Awards
Kurin, Inc. Named to Inc.’s Inaugural Best in Business List in the Prosperous and Thriving Category
December 8, 2020
Patents
Kurin, Inc. Receives Allowance from United States Patent and Trademark Office of Additional Claims to its Innovative Blood Culture Collection Device.
November 17, 2020
Industry
Kurin, Inc. Announces Agreement with Intalere for Kurin Lock to impact contaminated blood cultures
June 30, 2020
Awards
Kurin, Inc. Announces Agreement with Vizient for Kurin Lock to help reduce contaminated blood cultures
April 21, 2020
Patents
Kurin Inc. Responds to Allegations Published by Magnolia Medical Regarding Patent Infringement
March 14, 2019
Patents
Kurin, Inc. CEO Addresses Patent Infringement Lawsuit Brought by Magnolia Medical
February 12, 2019
Regulatory
Kurin, Inc. receives FDA 510k clearance for its novel Kurin Lock with peripheral IV infusion set.
January 30, 2019
Clinical Results
Kurin, Inc. announces clinical results on Kurin® efficacy from Central Texas Veterans Health Care System
October 16, 2018
Awards
Kurin, Inc. Announces Agreement with Premier for Kurin Lock® to help impact contaminated blood cultures
October 2, 2018
Performance
Kurin, Inc. Announces Educational Website on the Importance of Improving Value of the Blood Culture Test
September 18, 2018
Clinical Results
Clinical results of Kurin specimen diversion technology signal a shift in the blood culture collection standard of care.
August 31, 2018
Patents
Kurin, Inc. Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device
July 17, 2018
Clinical Results
Kurin, Inc. announces clinical study results of the Kurin Lock™ blood culture initial specimen diversion device at the APIC Annual Conference.
June 13, 2018
Subscribe to our newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.